FDA authorizes Pfizer, Moderna’s omicron boosters

In the first step toward the national rollout of omicron-updated COVID-19 vaccines, the FDA authorized Pfizer’s and Moderna’s candidates for emergency use Aug. 31. The CDC will meet for the next two days, and pending the agency’s OK, the boosters could be ready after Labor Day weekend.